The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics

APOPTOSIS ◽  
2011 ◽  
Vol 17 (2) ◽  
pp. 164-173 ◽  
Author(s):  
Carole Brosseau ◽  
Kay Colston ◽  
Angus George Dalgleish ◽  
Christine Galustian
2015 ◽  
Vol 21 ◽  
pp. 3291-3297 ◽  
Author(s):  
Xi Gu ◽  
Jian-Yi Li ◽  
Jiao Guo ◽  
Pi-Song Li ◽  
Wen-Hai Zhang

Sign in / Sign up

Export Citation Format

Share Document